Basic Materials / Specialty ChemicalsKSE
$4575.00
-105.00 (-2.24%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $4.8B · quality 49.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
42/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$106.7B
P/E
11.1x
↓EV/EBITDA
6.7x
↓ROE
7.5%
↑Gross Margin
8.1%
↓Debt/Equity
0.36
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-2.2%
FCF CAGR
+3.1%
FCF margin
1.6%
FCF / Net income
0.49x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $304.06B · net income $9.65B · FCF $4.76B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $304.06B | $304.06B | $330.34B | $282.35B | $324.93B |
| Net Income | $9.65B | $9.65B | $8.19B | $3.35B | $2.87B |
| EBITDA | $21.68B | $21.68B | $23.45B | $12.38B | $19.58B |
| EPS | 414.00 | 414.00 | 351.00 | 144.00 | 123.00 |
| Gross Margin | 8.1% | 8.1% | 8.4% | 6.3% | 9.5% |
| Operating Margin | 3.3% | 3.3% | 3.2% | 1.8% | 5.3% |
| Net Margin | 3.2% | 3.2% | 2.5% | 1.2% | 0.9% |
| Balance Sheet | |||||
| Debt/Equity | 0.36 | 0.36 | 0.39 | 0.40 | 0.30 |
| Current Ratio | 1.15 | 1.15 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $4.76B | $4.76B | $15.36B | $-7.36B | $4.35B |
| Returns | |||||
| ROE | 7.5% | 7.5% | 6.7% | 2.8% | 2.3% |
| Valuation | |||||
| P/E | 11.05 | 11.05 | 19.83 | 45.83 | 79.51 |
| EV/EBITDA | 6.68 | 6.68 | 8.56 | 15.71 | 12.92 |
| P/B | 0.83 | 0.83 | 1.33 | 1.28 | 1.86 |
| Growth & Yield | |||||
| Revenue Growth | -8.0% | -8.0% | 17.0% | -13.1% | — |
| EPS Growth | 17.9% | 17.9% | 143.8% | 17.1% | — |
| Dividend Yield | 5.1% | 5.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-0.7%
EPS terminal req.
$405.96
Spread vs growth
18.6%
5Y implied EPS CAGR
3.5%
EPS terminal req.
$491.21
Spread vs growth
14.5%
10Y implied EPS CAGR
6.7%
EPS terminal req.
$791.09
Spread vs growth
11.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-39.5%
Start / end P/E
23.5x → 11.1x
EPS bridge
351.00 → 414.00
Residual
-9.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.